You are here

Article Text

Article menu
Download PDFPDF
Letter
STAT4 single nucleotide polymorphism, rs7574865 G/T, as a risk for antiphospholipid syndrome
  1. T Horita,
  2. T Atsumi,
  3. N Yoshida,
  4. H Nakagawa,
  5. H Kataoka,
  6. S Yasuda,
  7. T Koike
  1. Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  1. T Horita, Department of Medicine II, Hokkaido University Graduate School of Medicine, N15 W7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan; thorita{at}med.hokudai.ac.jp

https://doi.org/10.1136/ard.2008.094367

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Genetic factors are hypothesised to play a role in the susceptibility to antiphospholipid syndrome (APS) based on several family studies in patients with anti-phospholipid antibodies (aPL) and/or clinical manifestations of APS. APS can occur alone (primary APS) or in conjunction with systemic lupus erythematosus (SLE). Therefore, APS and SLE may, in part, share a common mechanism for disease onset or progression. Likewise SLE, human leukocyte antigen (HLA) associations have been reported in APS.1 In addition, polymorphisms of target antigens for aPL and thrombotic genetic risk factors have been described.1 Despite the numerous studies on the immunogenetic predisposition to APS, only a few genes …

    View Full Text

    Footnotes

    • Competing interests: None declared.

    • Ethics approval: Obtained.